Free Trial

Medpace (MEDP) Competitors

Medpace logo
$498.60 -3.34 (-0.67%)
Closing price 09/19/2025 04:00 PM Eastern
Extended Trading
$493.39 -5.21 (-1.04%)
As of 09/19/2025 06:36 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

MEDP vs. ICLR, EHC, ELV, HIMS, IQV, TCOM, WCN, RDDT, AER, and CPAY

Should you be buying Medpace stock or one of its competitors? The main competitors of Medpace include ICON (ICLR), Encompass Health (EHC), Elevance Health (ELV), Hims & Hers Health (HIMS), IQVIA (IQV), Trip.com Group (TCOM), Waste Connections (WCN), Reddit (RDDT), Aercap (AER), and Corpay (CPAY).

Medpace vs. Its Competitors

Medpace (NASDAQ:MEDP) and Icon (NASDAQ:ICLR) are both large-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their earnings, media sentiment, analyst recommendations, profitability, risk, valuation, institutional ownership and dividends.

Medpace has a beta of 1.44, suggesting that its share price is 44% more volatile than the S&P 500. Comparatively, Icon has a beta of 1.2, suggesting that its share price is 20% more volatile than the S&P 500.

Medpace currently has a consensus price target of $422.27, suggesting a potential downside of 15.31%. Icon has a consensus price target of $216.67, suggesting a potential upside of 24.52%. Given Icon's stronger consensus rating and higher possible upside, analysts clearly believe Icon is more favorable than Medpace.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Medpace
3 Sell rating(s)
11 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
1.94
Icon
0 Sell rating(s)
8 Hold rating(s)
9 Buy rating(s)
2 Strong Buy rating(s)
2.68

Icon has higher revenue and earnings than Medpace. Icon is trading at a lower price-to-earnings ratio than Medpace, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Medpace$2.11B6.64$404.39M$13.4537.07
Icon$8.28B1.70$791.47M$9.7217.90

78.0% of Medpace shares are owned by institutional investors. Comparatively, 95.6% of Icon shares are owned by institutional investors. 20.3% of Medpace shares are owned by insiders. Comparatively, 44.0% of Icon shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

In the previous week, Medpace had 14 more articles in the media than Icon. MarketBeat recorded 20 mentions for Medpace and 6 mentions for Icon. Medpace's average media sentiment score of 1.31 beat Icon's score of 1.14 indicating that Medpace is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Medpace
16 Very Positive mention(s)
2 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Icon
5 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

Medpace has a net margin of 18.74% compared to Icon's net margin of 9.82%. Medpace's return on equity of 67.66% beat Icon's return on equity.

Company Net Margins Return on Equity Return on Assets
Medpace18.74% 67.66% 21.86%
Icon 9.82%10.95%6.23%

Summary

Medpace beats Icon on 9 of the 17 factors compared between the two stocks.

Get Medpace News Delivered to You Automatically

Sign up to receive the latest news and ratings for MEDP and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MEDP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MEDP vs. The Competition

MetricMedpaceMedical Services IndustryMedical SectorNASDAQ Exchange
Market Cap$14.01B$7.89B$5.78B$10.46B
Dividend YieldN/A2.77%5.61%4.61%
P/E Ratio37.07163.9780.5026.81
Price / Sales6.6472.29458.1393.30
Price / Cash35.7425.1737.6661.43
Price / Book18.7747.8015.756.39
Net Income$404.39M$241.92M$3.30B$271.80M
7 Day Performance1.62%87.88%5.35%3.51%
1 Month Performance9.98%48.98%7.28%9.58%
1 Year Performance36.34%39.26%80.79%28.53%

Medpace Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MEDP
Medpace
4.3145 of 5 stars
$498.60
-0.7%
$422.27
-15.3%
+36.3%$14.01B$2.11B37.075,900Positive News
High Trading Volume
ICLR
ICON
4.1832 of 5 stars
$177.81
+1.7%
$219.64
+23.5%
-42.6%$14.12B$8.28B13.5941,900Positive News
EHC
Encompass Health
4.8422 of 5 stars
$125.93
+0.3%
$134.00
+6.4%
+33.8%$12.65B$5.37B25.2740,000Analyst Forecast
Short Interest ↑
ELV
Elevance Health
4.9133 of 5 stars
$308.03
-1.8%
$411.06
+33.4%
-41.8%$70.62B$177.01B9.50104,200Positive News
HIMS
Hims & Hers Health
2.774 of 5 stars
$49.77
+2.8%
$38.92
-21.8%
+254.6%$10.94B$1.48B89.651,637Trending News
Insider Trade
IQV
IQVIA
4.9486 of 5 stars
$187.72
+0.0%
$229.86
+22.4%
-22.7%$31.91B$15.41B18.0388,000Positive News
TCOM
Trip.com Group
3.868 of 5 stars
$73.02
+0.3%
$76.98
+5.4%
+61.4%$47.55B$7.30B22.0641,073Positive News
WCN
Waste Connections
4.9214 of 5 stars
$178.44
-0.5%
$215.00
+20.5%
-2.7%$46.10B$8.92B36.3723,854Analyst Forecast
RDDT
Reddit
3.4514 of 5 stars
$230.54
-3.9%
$175.38
-23.9%
+302.7%$44.92B$1.30B218.182,233Trending News
Analyst Forecast
Insider Trade
AER
Aercap
2.2994 of 5 stars
$123.00
-0.4%
$122.57
-0.3%
+23.8%$23.07B$8.00B10.10740Short Interest ↑
CPAY
Corpay
4.374 of 5 stars
$311.60
-1.6%
$399.43
+28.2%
-1.8%$22.36B$3.97B16.8311,200Positive News
Analyst Downgrade

Related Companies and Tools


This page (NASDAQ:MEDP) was last updated on 9/21/2025 by MarketBeat.com Staff
From Our Partners